Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
2022studies shown
Showing 1,151-1,175 of 2,022
TerminatedNCT03741751

Repetitive TMS & Cognitive Training in Adults With Schizophrenia

This study exists to see whether a digital app or remote support tool is workable and worth testing more broadly. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 18 Years to 65 Years
Countries
United States
Sponsor
Washington University School of Medicine
Condition
Schizophrenia
CompletedNCT04554121

Efficacy of Personalizing Cognitive Remediation for Schizophrenia by Targeting Impairments in Early Auditory Processing

This study exists to understand how a digital app or remote support tool holds up over time after the earliest research stage. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 18 Years to 68 Years
Countries
United States
Sponsor
Columbia University
Condition
Schizophrenia
CompletedNCT07436481

The Effectiveness of Forest Therapy on Psychotic Patients: Focusing on Changes in Inflammatory Pathways and The Psychotic Condition of Patients

This study exists to see whether a therapy or guided support program can make care clearer and more responsive. Researchers are trying to understand whether a therapy or guided support program can improve sleep, daily rhythms, and longer-term stability.

SchizophreniaOtherFrom 18 Years to 60 Years
Countries
Indonesia
Sponsor
Natalia Dewi Wardani, MD
Condition
Schizophrenia
CompletedNCT07437365

Theta- and Alpha-Tuned Meditation for Negative Symptoms in Schizophrenia

This study exists to see whether a digital app or remote support tool can play a useful role in care. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 18 Years to 65 Years
Countries
Lebanon
Sponsor
Psychiatric Hospital of the Cross
Condition
Schizophrenia
WithdrawnNCT04369677

Thermoregulation Among Individuals With First-episode Psychosis

This study exists to explore whether a digital app or remote support tool could improve care and understanding. Researchers are trying to understand whether a digital app or remote support tool can improve sleep, daily rhythms, and longer-term stability.

SchizophreniaOtherFrom 18 Years to 35 Years
Countries
United States
Sponsor
Nicholas Breitborde
Condition
Schizophrenia
CompletedNCT07434388

LRFN5 and OLFM4 in Schizophrenia

This study exists to learn from real-world information that can show how a digital app or remote support tool fits into care. Researchers are trying to understand whether a digital app or remote support tool can give earlier or clearer feedback during care.

SchizophreniaOtherFrom 18 Years to 65 Years
Countries
Turkey
Sponsor
Elazığ Mental Health and Diseases Hospital
Condition
Schizophrenia
CompletedNCT07434401

α-N-acetylgalactosaminidase in Methamphetamine Psychosis

This study exists to learn from real-world information that can show how smoking support or smoking-related treatment fits into care. Researchers are trying to understand whether smoking support or smoking-related treatment can work better when mental health difficulties overlap with substance use.

SchizophreniaOtherFrom 18 Years to 65 Years
Countries
Turkey
Sponsor
Elazığ Mental Health and Diseases Hospital
Condition
Schizophrenia
CompletedNCT07141966

Assessment of Physical Activity, Balance, Muscle Strength, and Cognitive Function in Patients Diagnosed With Schizophrenia

This study exists to compare options and see whether a therapy or guided support program offers something meaningfully different. Researchers are trying to understand whether a therapy or guided support program can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 18 Years to 50 Years
Countries
Turkey
Sponsor
Dr. Lutfi Kirdar Kartal Training and Research Hospital
Condition
Schizophrenia
CompletedNCT04013555

The Effects of Kynurenine Aminotransferase Inhibition in People With Schizophrenia

This study exists to compare options and see whether blood tests and biological markers offers something meaningfully different. Researchers are trying to understand whether blood tests and biological markers can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 18 Years to 55 Years
Countries
United States
Sponsor
University of Maryland, Baltimore
Condition
Schizophrenia
CompletedNCT05110157

Journey Study: Evaluate the Efficacy, Safety, and Tolerability of Valbenazine as Adjunctive Treatment for Schizophrenia

This study exists to compare options and see whether a digital app or remote support tool offers something meaningfully different. Researchers are trying to understand how people respond to a digital app or remote support tool in practice and what may need to be adjusted.

SchizophreniaOtherOver 18 Years
Countries
Argentina, Bulgaria, Serbia, United States
Sponsor
Neurocrine Biosciences
Condition
Schizophrenia
CompletedNCT04857983

Memantine Augmentation of Targeted Cognitive Training in Schizophrenia

This study exists to compare options and see whether a digital app or remote support tool offers something meaningfully different. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 18 Years to 65 Years
Countries
United States
Sponsor
University of California, San Diego
Condition
Schizophrenia
CompletedNCT00183625

Supported Employment and Skills Training in Conjunction With Pharmacotherapy in Schizophrenia Patients

This study exists to compare options and see whether a therapy or guided support program offers something meaningfully different. Researchers are trying to understand what a therapy or guided support program could change in day-to-day care and decision-making.

SchizophreniaOtherFrom 18 Years to 60 Years
Countries
United States
Sponsor
University of California, Los Angeles
Condition
Schizophrenia
CompletedNCT02167724

Multicentre Evaluation of Bucco-dental Health in Patients With Schizophrenia in Côte d'Or

This study exists to learn from real-world information that can show how questionnaires and follow-up reports fits into care. Researchers are trying to understand what questionnaires and follow-up reports can reveal about signals in the brain or body that may guide care later on.

SchizophreniaOtherOver 18 Years
Countries
France
Sponsor
Centre Hospitalier Universitaire Dijon
Condition
Schizophrenia
TerminatedNCT05662306

C-Cog in Early Course Schizophrenia Study

This study exists to explore whether this type of care could improve care and understanding. For people living with Schizophrenia, that matters because care needs to work in daily life, not just in theory.

SchizophreniaOtherOver 18 Years
Countries
United States
Sponsor
University of Miami
Condition
Schizophrenia
CompletedNCT04860830

CONNEX-3: A Study to Test Whether Iclepertin Improves Learning and Memory in People With Schizophrenia

This study exists to learn from real-world information that can show how questionnaires and follow-up reports fits into care. Researchers are trying to understand whether questionnaires and follow-up reports can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 18 Years to 50 Years
Countries
Argentina, Austria, Belgium, Brazil, Bulgaria, China, Czech Republic, Denmark, Finland, Germany, Lithuania, Mexico, Portugal, Serbia, South Korea, Taiwan, United Kingdom, United States
Sponsor
Boehringer Ingelheim
Condition
Schizophrenia
CompletedNCT03238326

Safety and Tolerability of Open-Label Flexible-dose Brexpiprazole as Maintenance Treatment in Adolescents With Schizophrenia

This study exists to understand how a medication treatment holds up over time after the earliest research stage. Researchers are trying to understand how people respond to a medication treatment in practice and what may need to be adjusted.

SchizophreniaOtherFrom 13 Years to 17 Years
Countries
France, Italy, Mexico, Poland, Romania, Russian Federation, Serbia, Spain, Ukraine, United States
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition
Schizophrenia
SuspendedNCT04021719

OnTrackNY's Learning Healthcare System

This study exists to see whether a digital app or remote support tool can play a useful role in care. Researchers are trying to understand what helps a digital app or remote support tool stay useful, realistic, and easier to follow over time.

SchizophreniaOtherOver 16 Years
Countries
United States
Sponsor
New York State Psychiatric Institute
Condition
Schizophrenia
SuspendedNCT04589208

Glutamatergic Mechanisms of Psychosis and Target Engagement (SA1)

This study exists to see whether a digital app or remote support tool can make care clearer and more responsive. Researchers are trying to understand whether a digital app or remote support tool can better support energy, concentration, and everyday functioning.

SchizophreniaOtherFrom 18 Years to 55 Years
Countries
United States
Sponsor
New York State Psychiatric Institute
Condition
Schizophrenia
CompletedNCT07365982

Effect of Psychoeducation -Based Motivational Interviewing on Knowledge and Hope in Schizophrenia

This study exists to understand how psychoeducation, a guided learning and support program, holds up over time after the earliest research stage. Researchers are trying to understand what psychoeducation, a guided learning and support program, could change in day-to-day care and decision-making.

SchizophreniaOtherFrom 18 Years to 65 Years
Countries
Turkey
Sponsor
Büşra Taşkıner
Condition
Schizophrenia